Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.4 USD | -2.08% | -6.65% | +313.33% |
May. 08 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
May. 08 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
2.35B | - | - | - | |||
62.59B | - | |||||
41.18B | ||||||
40.29B | ||||||
27.9B | ||||||
26.21B |